These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18476258)

  • 1. The cellular metabolism and effects of gold complexes.
    Graham GG; Champion GD; Ziegler JB
    Met Based Drugs; 1994; 1(5-6):395-404. PubMed ID: 18476258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes--I. The effects of aurocyanide on the oxidative burst of polymorphonuclear leukocytes.
    Rudkowski R; Graham GG; Champion GD; Ziegler JB
    Biochem Pharmacol; 1990 Jun; 39(11):1687-95. PubMed ID: 2160817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes--II. Evidence for the formation and biological activity of aurocyanide.
    Graham GG; Dale MM
    Biochem Pharmacol; 1990 Jun; 39(11):1697-702. PubMed ID: 2160818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes. III. The formation of aurocyanide by myeloperoxidase.
    Graham GG; Kettle AJ
    Biochem Pharmacol; 1998 Aug; 56(3):307-12. PubMed ID: 9744567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cyanide on the uptake of gold by red blood cells.
    Graham GG; Haavisto TM; Jones HM; Champion GD
    Biochem Pharmacol; 1984 Apr; 33(8):1257-62. PubMed ID: 6424684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold complexes and activation of human polymorphonuclear leukocytes. Dissociation of changes in membrane potential and oxidative burst.
    Rudkowski R; Ziegler JB; Graham GG; Joulianos G
    Biochem Pharmacol; 1992 Sep; 44(6):1091-8. PubMed ID: 1417933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicinal chemistry of gold.
    Graham GG; Ziegler JB; Champion GD
    Agents Actions Suppl; 1993; 44():209-17. PubMed ID: 8103963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aurocyanide, dicyano-aurate (I), a pharmacologically active metabolite of medicinal gold complexes.
    Graham GG; Whitehouse MW; Bushell GR
    Inflammopharmacology; 2008 Jun; 16(3):126-32. PubMed ID: 18521543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin.
    Kim HY; Otgontenger U; Kim JW; Lee YJ; Kim SB; Lim SC; Kim YM; Kang KW
    Arch Pharm Res; 2023 Mar; 46(3):149-159. PubMed ID: 36894745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional pharmacology/toxicology V: ambivalent effects of thiocyanate upon the development and the inhibition of experimental arthritis in rats by aurothiomalate (Myocrysin®) and metallic silver.
    Whitehouse M; Butters D; Vernon-Roberts B
    Inflammopharmacology; 2013 Aug; 21(4):291-300. PubMed ID: 23686086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auranofin inhibits the activation pathways of polymorphonuclear leukocytes at multiple sites.
    Rudkowski R; Ziegler JB; Graham GG; Champion GD
    Biochem Pharmacol; 1991 Jun; 41(12):1921-9. PubMed ID: 1645553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of auranofin on antibody-dependent cellular cytotoxicity (ADCC) mediated by rat peripheral blood polymorphonuclear leukocytes and mononuclear cells.
    DiMartino MJ; Walz DT
    Inflammation; 1980 Sep; 4(3):279-88. PubMed ID: 6776048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gold compounds on function of phagocytic cells. Comparative inhibition of activated polymorphonuclear leukocytes and monocytes from rheumatoid arthritis and control subjects.
    Davis P; Johnston C
    Inflammation; 1986 Sep; 10(3):311-20. PubMed ID: 3017859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1H, 13C NMR, and electronic absorption spectroscopic studies of the interaction of cyanide with aurothiomalate.
    Graham GG; Bales JR; Grootveld MC; Sadler PJ
    J Inorg Biochem; 1985 Nov; 25(3):163-73. PubMed ID: 3934340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold levels produced by treatment with auranofin and sodium aurothiomalate.
    Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE
    Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auranofin modulates mast cell histamine and polymorphonuclear leukocyte collagenase release.
    Wojtecka-Lukasik E; Sopata I; Maśliński S
    Agents Actions; 1986 Apr; 18(1-2):68-70. PubMed ID: 2425596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation into the interactions of gold nanoparticles and anti-arthritic drugs with macrophages, and their reactivity towards thioredoxin reductase.
    James LR; Xu ZQ; Sluyter R; Hawksworth EL; Kelso C; Lai B; Paterson DJ; de Jonge MD; Dixon NE; Beck JL; Ralph SF; Dillon CT
    J Inorg Biochem; 2015 Jan; 142():28-38. PubMed ID: 25306263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ploidity and cell cycle progression during treatment with gold chloride, auranofin and sodium aurothiomalate. Studies on a human epithelial cell line and its sub-strains made resistant to the antiproliferative effects of these gold compounds.
    Glennås A; Rugstad HE
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 49(4):385-93. PubMed ID: 2867637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.